{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:09:05Z","timestamp":1777774145231,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005627","name":"Universit\u00e9 de Li\u00e8ge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019.107515RB.C21"],"award-info":[{"award-number":["PID2019.107515RB.C21"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SRA\/ 10.13039\/501100011033"],"award-info":[{"award-number":["SRA\/ 10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["JDC2022-049681-I"],"award-info":[{"award-number":["JDC2022-049681-I"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001671","name":"European Synchrotron Radiation Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023202","name":"Canadian Institute of Planners","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"ANRS Emerging Infectious Diseases","doi-asserted-by":"publisher","award":["ANR-10-LABX-77"],"award-info":[{"award-number":["ANR-10-LABX-77"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020230","name":"Government of Andalusia Ministry of Economic Transformation Industry Knowledge and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006393","name":"University of Granada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.150022","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:40:00Z","timestamp":1767685200000},"page":"150022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike\u2019s S2 subunit"],"prefix":"10.1016","volume":"340","author":[{"given":"Daniel","family":"Polo-Meg\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cano-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Trolese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"La Rocchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pierangelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Fongaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia Polverino","family":"de Laureto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Morales-Y\u00e1nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Vaneyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Vanderplasschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Decoville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Laumond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Carmen","family":"Salinas-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"C\u00e1mara-Artigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Gavira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Moog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Conejero-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.150022_bb0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.abn1755","article-title":"COVID-19 vaccination: the road ahead","volume":"373","author":"Altmann","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0010","article-title":"Role of COVID-19 vaccines in SARS-CoV-2 variants","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0015","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0035","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/v16050712","article-title":"Research Progress on spike-dependent SARS-CoV-2 fusion inhibitors and small molecules targeting the S2 subunit of spike","volume":"16","author":"Freidel","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/365113a0","article-title":"15_Jiang S_Nature-1993_HR2 derived peptides","volume":"365","author":"Jiang","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0055","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0060","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.abf4896","article-title":"Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets","volume":"371","author":"de Vries","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0065","first-page":"119","article-title":"Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein","volume":"40","author":"Yang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nsb1295-1075","article-title":"A trimeric structural domain of the HIV-1 transmembrane glycoprotein","volume":"2","author":"Lu","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0075","doi-asserted-by":"crossref","first-page":"25506","DOI":"10.1074\/jbc.M110.101170","article-title":"Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0080","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.201392898","article-title":"Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region","volume":"98","author":"Eckert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0085","doi-asserted-by":"crossref","first-page":"18207","DOI":"10.1073\/pnas.1413592112","article-title":"Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs","volume":"111","author":"Crespillo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00681-22","article-title":"Novel engineered SARS-CoV-2 HR1 trimer exhibits improved potency and broad-Spectrum activity against SARS-CoV-2 and its variants","volume":"96","author":"Bi","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0095","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.ijbiomac.2022.10.031","article-title":"Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity","volume":"222","author":"Cano-Mu\u00f1oz","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1080\/22221751.2022.2125348","article-title":"Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies, Emerg","volume":"11","author":"Huang","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40259-022-00529-7","article-title":"Passive immunotherapy against SARS-CoV-2: from plasma-based therapy to single potent antibodies in the race to stay ahead of the variants","volume":"36","author":"Strohl","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","article-title":"Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 omicron","volume":"185","author":"Cui","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0125","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2220582","article-title":"SARS-CoV-2 spike S2-specific neutralizing antibodies","volume":"12","author":"Li","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0135","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41422-022-00746-3","article-title":"A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein","volume":"32","author":"Pang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0140","article-title":"Identification of closed linear epitopes in S1-RBD and S2-HR1\/2 of SARS-CoV-2 spike protein able to induce neutralizing abs","volume":"11","author":"Watanabe","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1110\/ps.34602","article-title":"Single-domain antibody fragments with high conformational stability","volume":"11","author":"Dumoulin","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065994","article-title":"NANOBODIES\u00ae: a review of diagnostic and therapeutic applications","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0165","first-page":"19","article-title":"Annual review of animal biosciences applications of nanobodies","volume":"59","author":"Muyldermans","year":"2025"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biochi.2015.01.012","article-title":"Camelid single-domain antibody fragments: uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena","volume":"111","author":"Pain","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0175","article-title":"Ultrapotent broadly neutralizing human-llama bispecific antibodies against HIV-1, advanced","volume":"11","author":"Xu","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0180","article-title":"Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation","volume":"7","author":"Sun","year":"2024","journal-title":"Curr Res Microb Sci"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0185","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.abe3255","article-title":"An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike","volume":"13","author":"Schoof","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","article-title":"Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03866-z","article-title":"Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models","volume":"5","author":"Rossotti","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108401","article-title":"Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects","volume":"688","author":"Jurado","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040566","article-title":"Extremely thermostabilizing core mutations in coiled-coil mimetic proteins of hiv-1 gp41 produce diverse effects on target binding but do not affect their inhibitory activity","volume":"11","author":"Cano-mu\u00f1oz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143157","article-title":"Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes","volume":"310","author":"Polo-Meg\u00edas","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415511","article-title":"Exploring highly conserved regions of SARS-CoV-2 spike S2 subunit as targets for fusion inhibition using chimeric proteins","volume":"23","author":"Polo-Meg\u00edas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130132","article-title":"Investigating vulnerability of the conserved SARS-CoV-2 spike\u2019s heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins","volume":"262","author":"Polo-Meg\u00edas","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0225","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nprot.2014.039","article-title":"A general protocol for the generation of Nanobodies for structural biology","volume":"9","author":"Pardon","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0230","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/prot.23188","article-title":"Prediction of protein secondary structure from circular dichroism using theoretically derived spectra","volume":"80","author":"Louis-Jeune","year":"2012","journal-title":"Proteins: Structure, Function and Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1107\/S160057751400825X","article-title":"Developments in optics and performance at BL13-XALOC, the macromolecular crystallography beamline at the Alba synchrotron","volume":"21","author":"Juanhuix","year":"2014","journal-title":"J. Synchrotron Radiat."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0250","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1107\/S0907444913022750","article-title":"Phaser.MRage: automated molecular replacement","volume":"69","author":"Bunk\u00f3czi","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0255","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbamem.2017.05.006","article-title":"Crystallographic and biochemical characterization of the dimeric architecture of site-2 protease","volume":"1859","author":"Schacherl","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0260","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1038\/s41598-017-03457-7","article-title":"Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator","volume":"7","author":"Kromann-Hansen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.Refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0270","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0275","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/nar\/29.1.221","article-title":"PDBsum: summaries and analyses of PDB structures","volume":"29","author":"Laskowski","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijbiomac.2021.09.198","article-title":"Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors","volume":"192","author":"Cano-Mu\u00f1oz","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0300","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1080\/22221751.2022.2095308","article-title":"An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry, Emerg","volume":"11","author":"Lin","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0305","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.jmb.2020.08.010","article-title":"Probing vulnerability of the gp41 C-terminal heptad repeat as target for Miniprotein HIV inhibitors","volume":"432","author":"Jurado","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-0134(199610)26:2<123::AID-PROT2>3.0.CO;2-H","article-title":"The enthalpy change in protein folding and binding: refinement of parameters for structure-based calculations","volume":"26","author":"Hilser","year":"1996","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12861","article-title":"Factors in B cell competition and immunodominance","volume":"296","author":"Abbott","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0320","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0325","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052794","article-title":"Conformational stabilization of Gp41-mimetic Miniproteins opens up new ways of inhibiting HIV-1 fusion","volume":"23","author":"Cano-Mu\u00f1oz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174187","article-title":"Homology modeling-based in silico affnity maturation improves the affnity of a nanobody","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28196838","article-title":"In vitro affinity maturation of Nanobodies against Mpox virus A29 protein based on computer-aided design","volume":"28","author":"Yu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0345","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Xiang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12951-025-03150-2","article-title":"A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses","volume":"23","author":"Feng","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0355","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0360","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0370","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.chom.2020.11.004","article-title":"Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains","volume":"28","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.150022_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030642","article-title":"Broad epitope coverage of therapeutic multi-antibody combinations targeting SARS-CoV-2 boosts in vivo protection and neutralization potency to corner an immune-evading virus","volume":"12","author":"Roodink","year":"2024","journal-title":"Biomedicines"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:38:01Z","timestamp":1777484281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025105795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":75,"alternative-id":["S0141813025105795"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150022","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike\u2019s S2 subunit","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150022"}}